The Relationship of Melatonin to the Physiological Parameters of Pregnant Women During Period Pregnancy
DOI:
https://doi.org/10.63278/10.63278/mme.v31.1Keywords:
Melatonin, physiological parameters, pregnant women.Abstract
In recent times, there has been an explosive expansion in the comprehension of the hormone melatonin, particularly regarding its role in physiology, regulation, and therapeutic applications within various realms of clinical medicine. Melatonin serves as a vital biological agent capable of modulating mitochondrial performance, showcasing anti-inflammatory,antioxidant, and neuroprotective properties, promoting restful slumber, and bolstering the immune system. Moreover, it boasts bioavailability and minimal toxicity, positioning it as a promising candidate for the safe and effective treatment of an array of ailments while safeguarding human well-being. Within this manuscript, we endeavored to explore the significance of melatonin during the nascent stages of human existence, encompassing pregnancy, fetal development, and the newborn phase, through a thorough evaluation of contemporary literature.
References
Lerner, A.B.; Case, J.D.; Takahashi, Y.; Lee, T.H.; Mori, W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 1958, 80, 2587.
Back, K.; Tan, D.X.; Reiter, R.J. Melatonin biosynthesis in plants: Multiple pathways catalyze tryptophan to melatonin in the cytoplasm or chloroplasts. J. Pineal Res. 2016, 61, 426–437.
Hardeland, R.; Pandi-Perumal, S.R.; Cardinali, D.P. Melatonin. Int. J. Biochem. Cell Biol. 2006, 38, 313–316.
Hardeland, R.; Tan, D.X.; Reiter, R.J. Kynuramines, metabolites of melatonin and other indoles: The resurrection of an almost forgotten class of biogenic amines. J. Pineal Res. 2009, 47, 109–126.
Slominski, R.M.; Reiter, R.J.; Schlabritz-Loutsevitch, N.; Ostrom, R.S.; Slominski, A.T. Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol. Cell Endocrinol. 2012, 351, 152–166.
Ekmekcioglu, C. Melatonin receptors in humans: Biological role and clinical relevance. Biomed. Pharmacother. 2006, 60, 97–108.
Ma, H.; Kang, J.; Fan, W.; He, H.; Huang, F. ROR: Nuclear Receptor for Melatonin or Not? Molecules 2021, 26, 2693.
Reiter, R.J.; Mayo, J.C.; Tan, D.X.; Sainz, R.M.; Alatorre-Jimenez, M.; Qin, L. Melatonin as an Antioxidant: Under Promises but over Delivers. J. Pineal Res. 2016, 61, 253–278.
Tordjman, S.; Chokron, S.; Delorme, R.; Charrier, A.; Bellissant, E.; Jaafari, N.; Fougerou, C. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr. Neuropharmacol. 2017, 15, 434–443.
Carlomagno, G.; Minini, M.; Tilotta, M.; Unfer, V. From Implantation to Birth: Insight into Molecular Melatonin Functions. Int. J. Mol. Sci. 2018, 19, 2802.
Reiter, R.J.; Tan, D.X.; Korkmaz, A.; Rosales-Corral, S.A. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum. Reprod. Update 2014, 20, 293–307.
Lanoix, D.; Guérin, P.; Vaillancourt, C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: New insights into the role of this hormone in pregnancy. J. Pineal Res. 2012, 53, 417–425. [CrossRef
Landgraf, D.; Achten, C.; Dallmann, F.; Oster, H. Embryonic development and maternal regulation of murine circadian clock function. Chronobiol. Int. 2015, 32, 416–427.
Bulun, S.E. Endometriosis. N. Engl. J. Med. 2009, 360, 268–279.
Nnoaham, K.E.; Hummelshoj, L.; Webster, P.; d’Hooghe, T.; de Cicco Nardone, F.; de Cicco Nardone, C.; Jenkinson, C.; Kennedy, S.H.; Zondervan, K.T.; World Endometriosis Research Foundation Global Study of Women’s Health consortium. Reprint of: Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertil. Steril. 2019, 112, e137–e152.
Burney, R.O.; Giudice, L.C. Reprint of: Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 2019, 112, e153–e161.
Bulun, S.E.; Yilmaz, B.D.; Sison, C.; Miyazaki, K.; Bernardi, L.; Liu, S.; Kohlmeier, A.; Yin, P.; Milad, M.; Wei, J. Endometriosis. Endocr. Rev. 2019, 40, 1048–1079.
Marino, J.L.; Holt, V.L.; Chen, C.; Davis, S. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology. 2008, 19, 477–484.
Mosher, A.A.; Tsoulis, M.W.; Lim, J.; Tan, C.; Agarwal, S.K.; Leyland, N.A.; Foster, W.G. Melatonin activity and receptor expression in endometrial tissue and endometriosis. Hum. Reprod. 2019, 34, 1215–1224. [Google Scholar] [CrossRef]
You-Lin Tain 1,2,3 and Chien-Ning Hsu 4,5,”Melatonin Use during Pregnancy and Lactation Complicated by Oxidative Stress: Focus on Offspring’s Cardiovascular–Kidney– Metabolic Health in Animal Models “, 2024
Luiz Gustavo de Almeida Chuffa , “Melatonin Promotes Uterine and Placental Health: Potential Molecular Mechanisms “.
Chen, B.H.; Park, J.H.; Lee, Y.L.; Kang, I.J.; Kim, D.W.; Hwang, I.K.; Lee, C.-H.; Yan, B.C.; Kim, Y.-M.; Lee, T.-K.; et al. Melatonin improves vascular cognitive impairment induced by ischemic stroke by remyelination via activation of ERK1/2 signaling and restoration of glutamatergic synapses in the gerbil hippocampus. Biomed. Pharmacother. 2018, 108, 687–697. [CrossRef] [PubMed]
Hu, Y.; Wang, Z.; Pan, S.; Zhang, H.; Fang, M.; Jiang, H.; Zhang, H.; Gao, Z.; Xu, K.; Li, Z.; et al. Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats. Oncotarget 2017, 8, 31638–31654. Available online: https://pubmed.ncbi.nlm.nih.gov/28404943 (accessed on 1 October 2022). [CrossRef]
You-Lin Tain 1,2,3 and Chien-Ning Hsu 4,5,*Villapol, S.; Fau, S.; Renolleau, S.; Biran, V.; Charriaut-Marlangue, C.; Baud, O. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke.Pediatr. Res.2011, 69, 51–55. Available online: https://pubmed.ncbi.nlm.nih.gov/20856166 (accessed on 1 October 2022). [CrossRef].
Melatonin Use during Pregnancy and Lactation Complicated by Oxidative Stress: Focus on Offspring’s Cardiovascular–Kidney– Metabolic Health in Animal Models.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hanaa Dakheel Mezaala, Kh. G. Al-Fartosib, Mehdi El Arbi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their published articles online (e.g., in institutional repositories or on their website, social networks like ResearchGate or Academia), as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Except where otherwise noted, the content on this site is licensed under a Creative Commons Attribution 4.0 International License.



According to the